The most well-liked and most generally analyzed between selective androgen receptor modulators (SARMs), Ostarine —also called MK-2866, GTX 024, or Enobosarm —arrived to the scene again in the late 1990s as an experimental treatment for osteoporosis and selected health conditions that trigger insulin resistance, muscle losing, and muscle loss.Th